Synthetic CAS proteins R. Pérez Jiménez, B. Alonso Priority date: 2021(e)ko Maiatzaren 25a CAS DNA OWNERSHIP AND LICENSEE Owned by CIC nanoGUNE Licensed to Integra Therapeutics